Canada markets open in 8 hours 28 minutes

Arbutus Biopharma Corporation (ABUS)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
3.2100+0.1400 (+4.56%)
At close: 04:00PM EDT
3.1983 -0.01 (-0.36%)
After hours: 07:59PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 605.78M
Enterprise Value 478.23M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)41.89
Price/Book (mrq)5.28
Enterprise Value/Revenue 36.83
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 2.05
52-Week Change 325.39%
S&P500 52-Week Change 329.31%
52 Week High 33.2900
52 Week Low 31.6900
50-Day Moving Average 32.7774
200-Day Moving Average 32.3303

Share Statistics

Avg Vol (3 month) 31.14M
Avg Vol (10 day) 3662.85k
Shares Outstanding 5188.72M
Implied Shares Outstanding 6188.72M
Float 8135.49M
% Held by Insiders 122.29%
% Held by Institutions 144.30%
Shares Short (Apr 30, 2024) 45.81M
Short Ratio (Apr 30, 2024) 42.92
Short % of Float (Apr 30, 2024) 43.91%
Short % of Shares Outstanding (Apr 30, 2024) 43.08%
Shares Short (prior month Mar 28, 2024) 44.55M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:5
Last Split Date 3Nov 04, 2010

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-1,252.15%

Management Effectiveness

Return on Assets (ttm)-29.31%
Return on Equity (ttm)-57.54%

Income Statement

Revenue (ttm)12.99M
Revenue Per Share (ttm)0.08
Quarterly Revenue Growth (yoy)-77.10%
Gross Profit (ttm)N/A
EBITDA -78.65M
Net Income Avi to Common (ttm)-74.39M
Diluted EPS (ttm)-0.4400
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)129.24M
Total Cash Per Share (mrq)0.69
Total Debt (mrq)8.08M
Total Debt/Equity (mrq)7.05%
Current Ratio (mrq)6.70
Book Value Per Share (mrq)0.64

Cash Flow Statement

Operating Cash Flow (ttm)-77.93M
Levered Free Cash Flow (ttm)-46.04M